Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
This study is currently recruiting participants.
Study NCT00026312
Information provided by National Cancer Institute (NCI)
First Received: November 9, 2001
Last Updated: November 17, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
